Invention Grant
- Patent Title: 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
-
Application No.: US16504376Application Date: 2019-07-08
-
Publication No.: US11185537B2Publication Date: 2021-11-30
- Inventor: Rohan Eric John Beckwith , Simone Bonazzi , Artiom Cernijenko , Fupeng Ma , Nathaniel F. Ware
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/454 ; A61P35/00 ; A61K31/4545 ; A61K31/498 ; C07D401/04
Abstract:
The present disclosure provides a compound of Formula (I′): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein Ra, Rb, Rx, R1, R2, X2, and q are as defined herein, and methods of making and using same.
Public/Granted literature
- US20200016143A1 3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Public/Granted day:2020-01-16
Information query
